trending Market Intelligence /marketintelligence/en/news-insights/trending/dw2dfmEnkVFfwnvqxel_nw2 content esgSubNav
In This List

CSPC Pharmaceutical executive director retires

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


CSPC Pharmaceutical executive director retires

Lu Jianmin resigned as an executive director of CSPC Pharmaceutical Group Ltd., effective immediately.

Jianmin is stepping down due to his retirement from the board.